Dipyridamole is a phosphodiesterase inhibitor and adenosine re-uptake blocker with vasodilatory and antiplatelet properties, used as an adjunct to oral anticoagulants for mechanical heart valve thromboprophylaxis, and intravenously as a pharmacological cardiac stress-test agent. Simson Pharma's Dipyridamole reference standard and impurities support compendial testing across these cardiovascular applications.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Dipyridamole Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.
